Skip to content
Screener

Biote Corp. BTMD Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$44.2MMiss by $1.9M
EPS-$0.23Miss by $0.26
Revenue estimate$46.1M
EPS estimate$0.03
“Over the past year Biote has achieved meaningful progress in advancing our strategic initiatives, driving fundamental improvements that we believe position the Company to achieve sustainable procedure revenue growth. While not yet evident in our financial results, these foundational improvements have strengthened the core of our business and enhanced our resiliency, which we expect will drive improved financial performance in the second half.”
Bob Peterson

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$44.0M
EPS estimate-$0.05

Financials

Q2 2026

Income statement

See full
Revenue$44.2M-9.5%
Gross profit$28.9M-17.3%
Operating income-$3.5M-133%
Net income-$6.6M-306%
EPS (diluted)-$0.23-330%

Balance sheet

See full
Cash & equivalents$11.2M-43.0%
Total debt$128.6M+19.2%
Total equity-$65.8M+22.7%
Total assets$101.7M-3.0%

Cash flow

See full
CapEx$2.6M+41.3%
Free cash flow-$3.7M-171%

Valuation & ratios

Valuation

as of 10/09/26
See full
Market cap$33.55M-63.0%
Enterprise value$151.02M-10.6%
P/E5.7×+2.6×
P/S0.2×-0.3×

Profitability

See full
Gross margin68.6%-3.4pp
Operating margin8%-9.7pp
Net margin3.2%-12.5pp
FCF margin10.8%-6.7pp

Returns & leverage

See full
Current ratio1.4×+0.5×

Segments

By product

See full
Product Revenue$43.4M-9.0%
Pellet Procedures Product Revenue$30.3M-13.9%
Dietary Supplements$11.4M+5.7%
Disposable Trocars Product Revenue$1.2M-1.5%
Shipping Fees And Other Product Revenue$505.0K+6.5%

FAQ

When did Biote Corp. report Q2 2026 earnings?
Biote Corp. (BTMD) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Biote Corp.'s Q2 2026 revenue and EPS?
Biote Corp. reported revenue of $44.2M and eps of $-0.23 for Q2 2026.
Did Biote Corp. beat estimates in Q2 2026?
Revenue missed the consensus estimate of $46.1M by $1.9M. EPS missed the consensus estimate of $0.03 by $0.26.
How did Biote Corp.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.5% from $48.9M a year earlier.
Where can I find Biote Corp.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-335200) and the 10-Q periodic report (0001193125-26-340364) directly on SEC EDGAR. The filing index links above go to sec.gov.